Ouro Fino Saúde Animal Participações S.A Asset Resilience Ratio
Ouro Fino Saúde Animal Participações S.A asset resilience ratio. Ouro Fino Saúde Animal Participações S.A (OFSA3) has an Asset Resilience Ratio of 10.18% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Ouro Fino Saúde Animal Participações S.A total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Ouro Fino Saúde Animal Participações S.A (2011–2024)
Asset resilience ratio of Ouro Fino Saúde Animal Participações S.A from 2011 to 2024. This chart shows how Ouro Fino Saúde Animal Participações S.A's Asset Resilience Ratio has changed over time. See free cash flow generation of Ouro Fino Saúde Animal Participações S.A to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down Ouro Fino Saúde Animal Participações S.A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Ouro Fino Saúde Animal Participações S.A assets under control.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | R$135.15 Million | 10.18% |
| Short-term Investments | R$0.00 | 0% |
| Total Liquid Assets | R$135.15 Million | 10.18% |
Asset Resilience Insights
- Moderate Liquidity: Ouro Fino Saúde Animal Participações S.A has 10.18% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Ouro Fino Saúde Animal Participações S.A Industry Peers by Asset Resilience Ratio
Compare Ouro Fino Saúde Animal Participações S.A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Galderma Group N
SW:GALD |
Drug Manufacturers - Specialty & Generic | 3.56% |
|
Enzymatica publ AB
ST:ENZY |
Drug Manufacturers - Specialty & Generic | 22.17% |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
Drug Manufacturers - Specialty & Generic | 9.04% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 47.16% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Walvax BioTech
SHE:300142 |
Drug Manufacturers - Specialty & Generic | 2.20% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
Ouro Fino Saúde Animal Participações S.A Asset Resilience Ratio by Year (2011–2024)
Ouro Fino Saúde Animal Participações S.A asset resilience ratio by year from 2011 to 2024. The table below shows the annual Asset Resilience Ratio data for Ouro Fino Saúde Animal Participações S.A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 16.12% | R$223.26 Million ≈ $43.81 Million |
R$1.38 Billion ≈ $271.70 Million |
-6.56pp |
| 2023-12-31 | 22.68% | R$290.13 Million ≈ $56.93 Million |
R$1.28 Billion ≈ $250.96 Million |
+11.48pp |
| 2022-12-31 | 11.21% | R$150.92 Million ≈ $29.61 Million |
R$1.35 Billion ≈ $264.21 Million |
-14.45pp |
| 2021-12-31 | 25.66% | R$305.99 Million ≈ $60.04 Million |
R$1.19 Billion ≈ $234.02 Million |
+4.27pp |
| 2020-12-31 | 21.38% | R$236.04 Million ≈ $46.32 Million |
R$1.10 Billion ≈ $216.61 Million |
+12.61pp |
| 2019-12-31 | 8.78% | R$76.32 Million ≈ $14.97 Million |
R$869.54 Million ≈ $170.62 Million |
-4.94pp |
| 2018-12-31 | 13.71% | R$116.02 Million ≈ $22.77 Million |
R$846.01 Million ≈ $166.00 Million |
-13.35pp |
| 2017-12-31 | 27.07% | R$219.31 Million ≈ $43.03 Million |
R$810.23 Million ≈ $158.98 Million |
+10.02pp |
| 2016-12-31 | 17.04% | R$132.19 Million ≈ $25.94 Million |
R$775.58 Million ≈ $152.18 Million |
+17.04pp |
| 2015-12-31 | 0.00% | R$22.00K ≈ $4.32K |
R$693.37 Million ≈ $136.05 Million |
-1.65pp |
| 2014-12-31 | 1.65% | R$10.38 Million ≈ $2.04 Million |
R$627.26 Million ≈ $123.08 Million |
+1.10pp |
| 2013-12-31 | 0.55% | R$2.98 Million ≈ $585.12K |
R$538.68 Million ≈ $105.70 Million |
+0.36pp |
| 2012-12-31 | 0.20% | R$887.00K ≈ $174.05K |
R$452.13 Million ≈ $88.72 Million |
+0.18pp |
| 2011-12-31 | 0.02% | R$88.00K ≈ $17.27K |
R$465.91 Million ≈ $91.42 Million |
-- |
About Ouro Fino Saúde Animal Participações S.A
Ouro Fino Saúde Animal Participações S.A., together with its subsidiaries, engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals primarily in Brazil. The company operates through three segments: Production Animals; Companion Animals; and International Operations. It manufactures and trades in medicines, including an… Read more